NCT03030430View on ClinicalTrials.gov

Study of Bevacizumab(BAT1706) and Comparators in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

March 15, 2016

Primary Completion Date

May 16, 2017

Study Completion Date

June 28, 2017

Conditions
NSCLC
Interventions
BIOLOGICAL

BAT1706 injection

1mg/kg, IV on day 1

BIOLOGICAL

EU-sourced Avastin

1mg/kg, IV on day 1

BIOLOGICAL

US-sourced Avastin

1mg/kg, IV on day 1

Trial Locations (1)

8011

Christchurch Clinical Studies Trust Ltd (CCST), Christchurch

Sponsors
All Listed Sponsors
lead

Bio-Thera Solutions

INDUSTRY